Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-15-005296
Filing Date
2015-09-24
Accepted
2015-09-24 21:56:16
Documents
1
Period of Report
2015-09-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT gff4_goldberg092415.html 4  
1 OWNERSHIP DOCUMENT gff4_goldberg092415.xml 4 57113
  Complete submission text file 0001171843-15-005296.txt   58491
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
GOLDBERG Y. PAUL (Reporting) CIK: 0001619960 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 151123923